Activists seek early decision on better access to life-saving breast cancer medicine
Activists are urging the Kerala High Court to expedite a long-pending case regarding access to expensive, life-saving breast cancer medications. The petition seeks to address the high cost of drugs like Ribociclib for patients in need.
Why it matters
The case addresses the critical intersection of patent law, pharmaceutical pricing, and the fundamental right to healthcare for cancer patients.
Seeking to expedite the final hearing involving access to breast cancer medicine Ribociclib, activists batting for the right to healthcare have written to the Chief Justice of the Kerala High Court Soumen Sen to end a prolonged delay and ensure timely access for patients who urgently need the life-saving medicine.
The case has been pending before the Kerala High Court since June 2022, and the writ petition has been listed 57 times for final hearing without the case being heard since January 21, 2023, the Working Group on Access to Medicines and Treatment said in its letter.
The letter has also been sent to the President of India Droupadi Murmu and the Chief Justice of India Justice Surya Kant.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in